Compound Evidence File
#EC-2026-0906
Cardiogen
Filed under Peptides. The bureau holds 175 laboratory returns for this compound from 68 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
68 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 8 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Jan 2026 | 18 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Dec 2025 | 8 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Jun 2026 | 9 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 2 Apr 2026 | 2 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 7 May 2026 | 1 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Nov 2025 | 1 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 9.9 | 10.0 | 4 Apr 2026 | 26 Apr 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Jan 2026 | 6 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Mar 2026 | 26 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 10.0 | 10.0 | 22 Mar 2026 | 3 Jul 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 10.0 | 10.0 | 10.0 | 27 Feb 2025 | 27 Feb 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 18 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Jan 2026 | 9 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Dec 2025 | 8 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Dec 2025 | 11 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 12 Dec 2025 | 22 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 9.9 | 9.9 | 10.0 | 17 Jan 2026 | 4 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 28 Mar 2026 | 5 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 9.9 | 9.9 | 10.0 | 17 Dec 2025 | 3 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Jan 2026 | 14 Feb 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Apr 2026 | 12 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 9.9 | 22 Mar 2026 | 12 May 2026 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 9.3 | 9.3 | 9.3 | 6 May 2025 | 6 May 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 9.2 | 9.0 | 9.5 | 14 Jan 2025 | 19 Jan 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 9.1 | 8.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.9 | 7.4 | 9.7 | 25 May 2026 | 25 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 3 | 8.9 | 8.3 | 9.9 | 9 Jun 2025 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.8 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Planet PeptideCASE #VI-2026-0092 | X | 2 | 8.8 | 8.2 | 9.3 | 24 Apr 2025 | 21 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 | 8 Jul 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.5 | 7.9 | 9.7 | 24 May 2026 | 24 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 8.5 | 8.5 | 8.5 | 7 May 2025 | 7 May 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.4 | 7.0 | 9.8 | 24 May 2026 | 24 May 2026 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 8.4 | 8.4 | 8.4 | 25 Apr 2025 | 25 Apr 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 4 | 7.9 | 7.1 | 9.1 | 7 May 2025 | 17 May 2026 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 7.9 | 7.9 | 7.9 | 13 Jun 2025 | 13 Jun 2025 |
| PeptiSlimCASE #VI-2026-0557 | X | 1 | 7.8 | 7.8 | 7.8 | 20 Jun 2025 | 20 Jun 2025 |
| Reta-PeptideCASE #VI-2026-0756 | X | 6 | 7.4 | 6.1 | 10.0 | 7 May 2025 | 24 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 7.4 | 6.8 | 8.0 | 24 Apr 2025 | 25 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 7.4 | 7.4 | 7.4 | 17 Dec 2024 | 17 Dec 2024 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 7.2 | 7.1 | 7.3 | 13 Feb 2025 | 26 Jan 2026 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 7.2 | 7.2 | 7.2 | 16 Mar 2025 | 16 Mar 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.1 | 7.1 | 7.1 | 25 Apr 2025 | 25 Apr 2025 |
| TydesCASE #VI-2026-0493 | X | 2 | 7.0 | 6.6 | 7.5 | 13 Jun 2025 | 24 May 2026 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 7.0 | 7.0 | 7.0 | 3 Jul 2025 | 3 Jul 2025 |
| UtherCASE #VI-2026-0902 | X | 6 | 6.9 | 5.1 | 10.0 | 28 Mar 2025 | 24 May 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 | 3 Jun 2025 |
| Yabang PeptideCASE #VI-2026-0148 | X | 1 | 6.7 | 6.7 | 6.7 | 3 Jun 2025 | 3 Jun 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 1 | 6.6 | 6.6 | 6.6 | 13 Feb 2025 | 13 Feb 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 6.5 | 5.6 | 7.5 | 24 Apr 2025 | 20 May 2026 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 6.4 | 6.4 | 6.4 | 3 Jun 2025 | 3 Jun 2025 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 6.4 | 6.4 | 6.4 | 14 Jan 2025 | 14 Jan 2025 |
| SRY LabsCASE #VI-2026-0657 | X | 3 | 6.1 | 5.4 | 7.2 | 3 Jun 2025 | 23 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 5.8 | 5.5 | 6.0 | 27 Feb 2025 | 21 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 1 | 5.3 | 5.3 | 5.3 | 6 May 2025 | 6 May 2025 |
| Hunan GoodPeptides Biotech CoCASE #VI-2026-0370 | X | 1 | 5.3 | 5.3 | 5.3 | 28 Mar 2025 | 28 Mar 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 | 13 Jun 2025 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 5.1 | 5.1 | 5.1 | 20 Jun 2025 | 20 Jun 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 4.9 | 4.9 | 4.9 | 13 Jun 2025 | 13 Jun 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 4.9 | 4.9 | 4.9 | 8 Jul 2025 | 8 Jul 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 4.3 | 4.3 | 4.3 | 2 Jul 2025 | 2 Jul 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 2 | 4.0 | 3.4 | 4.5 | 3 Jun 2025 | 21 May 2026 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 2.6 | 2.6 | 2.6 | 20 Jun 2025 | 20 Jun 2025 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 1.4 | 1.4 | 1.4 | 28 Mar 2025 | 28 Mar 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for Cardiogen alone.